Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,878 | 30,215 | 33,428 | 36,567 | 45,744 |
| Receivables | 207 | 216 | 227 | 302 | 369 |
| TOTAL | $26,782 | $31,638 | $34,696 | $38,519 | $47,258 |
| Non-Current Assets | |||||
| PPE Net | 250 | 277 | 200 | 224 | 228 |
| Intangibles | 156 | 173 | 188 | 202 | 227 |
| TOTAL | $406 | $450 | $388 | $426 | $454 |
| Total Assets | $27,188 | $32,087 | $35,085 | $38,945 | $47,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,957 | 5,360 | 5,332 | 4,970 | 7,180 |
| Other current liabilities | 176 | 604 | 895 | 256 | 323 |
| TOTAL | $6,145 | $5,985 | $6,262 | $5,264 | $7,542 |
| Non-Current Liabilities | |||||
| TOTAL | $117 | $113 | $N/A | $7 | $17 |
| Total Liabilities | $6,263 | $6,098 | $6,262 | $5,270 | $7,559 |
| Shareholders' Equity | |||||
| Common Shares | 110,023 | 110,136 | 109,840 | 109,130 | 113,492 |
| Retained earnings | -105,621 | -100,571 | -95,957 | -89,841 | -88,034 |
| Other shareholders' equity | 2,606 | 2,622 | 2,617 | 2,600 | 2,706 |
| TOTAL | $20,925 | $25,989 | $28,822 | $33,675 | $40,154 |
| Total Liabilities And Equity | $27,188 | $32,087 | $35,085 | $38,945 | $47,712 |